FR2125248B1 - - Google Patents

Info

Publication number
FR2125248B1
FR2125248B1 FR7120247A FR7120247A FR2125248B1 FR 2125248 B1 FR2125248 B1 FR 2125248B1 FR 7120247 A FR7120247 A FR 7120247A FR 7120247 A FR7120247 A FR 7120247A FR 2125248 B1 FR2125248 B1 FR 2125248B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7120247A
Other languages
French (fr)
Other versions
FR2125248A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Pharmacal Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharmacal Co filed Critical Norwich Pharmacal Co
Publication of FR2125248A1 publication Critical patent/FR2125248A1/fr
Application granted granted Critical
Publication of FR2125248B1 publication Critical patent/FR2125248B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7120247A 1971-02-12 1971-06-03 Expired FR2125248B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11504571A 1971-02-12 1971-02-12

Publications (2)

Publication Number Publication Date
FR2125248A1 FR2125248A1 (enExample) 1972-09-29
FR2125248B1 true FR2125248B1 (enExample) 1975-08-01

Family

ID=22358997

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7120247A Expired FR2125248B1 (enExample) 1971-02-12 1971-06-03

Country Status (8)

Country Link
US (1) US3751404A (enExample)
JP (1) JPS5414103B1 (enExample)
AT (1) AT333986B (enExample)
DE (1) DE2127393C3 (enExample)
ES (1) ES391701A1 (enExample)
FR (1) FR2125248B1 (enExample)
IL (1) IL36869A (enExample)
PH (3) PH13821A (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907762A (en) * 1971-12-27 1975-09-23 Univ Sherbrooke Angiotensin{hd II {B position 8 analogs
US4250086A (en) * 1979-11-19 1981-02-10 Ortho Pharmaceutical Corporation Method and composition for preparation of H-SAR-LYS-SAR-GLN-NH2
HU191961B (en) * 1984-08-02 1987-04-28 Richter Gedeon Vegyeszet Process for producing 1,5 and 8 substituted peptides of angiotenzin-ii antagonistic activity
JPH05503691A (ja) * 1989-12-29 1993-06-17 ユニバーシティ・テクノロジーズ・インターナショナル・インコーポレイテッド アゴニストおよびアンタゴニストを含む生物学的に活性なリガンドの３次構造モデルの設計方法およびアンギオテンシンに基づいた新規合成アンタゴニスト
AU7034791A (en) * 1989-12-29 1991-07-24 University Technologies International Inc. Methods for modelling tertiary structures of biologically active ligands including agonists and antagonists thereto and novel synthetic antagonists based on angiotensin
CN102333536B (zh) 2008-12-29 2014-08-13 特维那公司 β-抑制蛋白效应器和组合物以及其应用方法
CA2938986A1 (en) 2014-02-07 2015-08-13 Trevena, Inc. Crystalline and amorphous forms of a beta-arrestin effector
CN106456698B (zh) * 2014-05-19 2022-05-17 特维娜有限公司 β-抑制蛋白效应物的合成
JP7026575B2 (ja) 2018-05-22 2022-02-28 株式会社ニューフレアテクノロジー 電子ビーム照射方法、電子ビーム照射装置、及びプログラム

Also Published As

Publication number Publication date
DE2127393C3 (de) 1980-07-10
PH17092A (en) 1984-05-29
IL36869A0 (en) 1971-07-28
AT333986B (de) 1976-12-27
PH17100A (en) 1984-05-29
DE2127393B2 (de) 1979-09-20
FR2125248A1 (enExample) 1972-09-29
US3751404A (en) 1973-08-07
DE2127393A1 (de) 1972-09-07
ES391701A1 (es) 1973-06-16
JPS5414103B1 (enExample) 1979-06-05
ATA483471A (de) 1976-04-15
PH13821A (en) 1980-10-03
IL36869A (en) 1974-11-29

Similar Documents

Publication Publication Date Title
ATA136472A (enExample)
FR2125248B1 (enExample)
AR196074A1 (enExample)
AU2658571A (enExample)
AU2691671A (enExample)
AU2894671A (enExample)
AU2742671A (enExample)
AU2726271A (enExample)
AU2941471A (enExample)
AU2564071A (enExample)
AU2684071A (enExample)
AU2952271A (enExample)
AU2485671A (enExample)
AU3005371A (enExample)
AU2473671A (enExample)
AU2836771A (enExample)
AU3038671A (enExample)
AU2577671A (enExample)
AU2588771A (enExample)
AU2654071A (enExample)
AU2486471A (enExample)
AU3025871A (enExample)
AU2938071A (enExample)
AU2684171A (enExample)
AU2456871A (enExample)

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property